JPM23: Takeda tests Bristol Myers, Prime weighs spinoffs and Sanofi faces down a competitor

JPM23: Takeda tests Bristol Myers, Prime weighs spinoffs and Sanofi faces down a competitor

Source: 
BioPharma Dive
snippet: 

Executives at the two pharmas talked up their rival drugs at the J.P. Morgan Healthcare Conference, while Prime Medicine’s CEO pondered a busy future.